May 10 |
Vanda Pharmaceuticals Reports Mixed Q1 2024 Results, Misses Revenue Estimates
|
May 9 |
Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) Q1 2024 Earnings Call Transcript
|
May 9 |
Q1 2024 Vanda Pharmaceuticals Inc Earnings Call
|
May 9 |
Vanda Pharmaceuticals Inc (VNDA) (Q1 2024) Earnings Call Transcript Highlights: Navigating ...
|
May 9 |
Vanda Pharmaceuticals, Inc. (VNDA) Q1 2024 Earnings Call Transcript
|
May 8 |
Vanda Pharmaceuticals GAAP EPS of -$0.07, revenue of $47.46M
|
May 8 |
Vanda Pharmaceuticals Reports First Quarter 2024 Financial Results
|
May 7 |
Vanda Pharmaceuticals Confirms Receipt of Revised Unsolicited Takeover Proposal from Future Pak
|
May 7 |
Vanda Pharmaceuticals up 15% as Future Pak sweetens bid
|
May 7 |
UPDATE 2-Future Pak sweetens take-private offer for Vanda Pharmaceuticals
|